PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Anaphylaxis D000707 35 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Ascariasis D001196 3 associated lipids
Asthma D001249 52 associated lipids
Astrocytoma D001254 15 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Bronchial Spasm D001986 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Catalepsy D002375 30 associated lipids
Cataract D002386 34 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Brain Ischemia D002545 89 associated lipids
Cholangitis D002761 3 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Cough D003371 19 associated lipids
Cryptococcosis D003453 3 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dehydration D003681 11 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dirofilariasis D004184 3 associated lipids
Down Syndrome D004314 18 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Erythema D004890 22 associated lipids
Fever D005334 35 associated lipids
Fibrosis D005355 23 associated lipids
Folliculitis D005499 7 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Glioma D005910 112 associated lipids
Goiter D006042 4 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Headache D006261 4 associated lipids
Hematoma D006406 5 associated lipids
Hemolysis D006461 131 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperemia D006940 25 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypotension D007022 41 associated lipids
Hypothermia D007035 19 associated lipids
Inflammation D007249 119 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Leiomyoma D007889 8 associated lipids
Leukemia D007938 74 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Melanoma D008545 69 associated lipids
Meningoencephalitis D008590 4 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Myocardial Infarction D009203 21 associated lipids
Nasal Polyps D009298 26 associated lipids
Nerve Degeneration D009410 53 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Zhuang H et al. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. 2003 Ann. N. Y. Acad. Sci. pmid:12853315
Figueiredo-Pereira ME et al. Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration. 2016 Ann. N. Y. Acad. Sci. pmid:26748744
Padilla J et al. PPAR-gamma-mediated regulation of normal and malignant B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818446
Padilla J et al. Effects of 15-deoxy-delta 12,14-PGJ2 on B lineage cells. 2000 Ann. N. Y. Acad. Sci. pmid:10818475
Wolfe LS and Pellerin L Arachidonic acid metabolites in the rat and human brain. New findings on the metabolism of prostaglandin D2 and lipoxygenase products. 1989 Ann. N. Y. Acad. Sci. pmid:2570544
Fukushima M et al. Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results. 1994 Ann. N. Y. Acad. Sci. pmid:7825837
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Gayarre J et al. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. 2007 Ann. N. Y. Acad. Sci. pmid:17405918
Okuyama S et al. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2. 1985 Ann. N. Y. Acad. Sci. pmid:3868328
Kim DH et al. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723057
Song NY et al. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723058
Cha B et al. 15-Deoxy-delta 12, 14,-prostaglandin J2 suppresses nuclear factor-kappaB-mediated apoptosis of Helicobacter pylori-infected gastric epithelial cells. 2009 Ann. N. Y. Acad. Sci. pmid:19723089
Norman P et al. BAY u3405 is a potent and competitive antagonist of U46619, PGD2 and 9 alpha, 11 beta PGF2 alpha-induced contractions of airway smooth muscle. 1991 Ann. N. Y. Acad. Sci. pmid:1952564
Nowak D et al. Comparison of airway responsiveness to prostaglandin D2 and histamine, methacholine or exercise in healthy and asthmatic subjects. 1991 Ann. N. Y. Acad. Sci. pmid:1952573
Kim EH et al. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. 2006 Ann. N. Y. Acad. Sci. pmid:17384282
Rangachari PK Concerning prostaglandin D2: forgotten, promiscuous, capricious. 1992 Ann. N. Y. Acad. Sci. pmid:1456655
Zhao X et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. 2007 Ann. Neurol. pmid:17457822
Liu JJ et al. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. 2005 Ann. Oncol. pmid:15642706
Brodsky L et al. Arachidonic acid metabolites in middle ear effusions of children. 1991 Ann. Otol. Rhinol. Laryngol. pmid:1648326
Shimizu T et al. A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage. 2006 Ann. Surg. pmid:16794398
Scott HW et al. Hazards in operative management of patients with systemic mastocytosis. 1983 Ann. Surg. pmid:6189461
Austen KF Doing what I like. 2008 Annu. Rev. Immunol. pmid:17877459
Chen SY et al. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress. 2002 Anticancer Drugs pmid:12187333
Eucker J et al. Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. 2004 Anticancer Drugs pmid:15514564
Fulzele SV et al. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. 2007 Anticancer Drugs pmid:17159504
Eucker J et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. 2006 Anticancer Drugs pmid:16926626
Dionne S et al. PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis. 2010 Anticancer Res. pmid:20150631
el Attar TM and Virji AS Effects of indomethacin, cisplatin and delta 12-prostaglandin J2 on growth of oral squamous carcinoma cells. 1997 Nov-Dec Anticancer Res. pmid:9494540
Tejedor M et al. Potentiation of radiation toxicity in C-6 glioma cells by prostaglandin D2. 1989 Jul-Aug Anticancer Res. pmid:2817802
Conde B et al. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. 1991 Jan-Feb Anticancer Res. pmid:1902073
Pica F et al. Delta(12)-prostaglandin J(2) is a potent inhibitor of influenza A virus replication. 2000 Antimicrob. Agents Chemother. pmid:10602750
Conti C et al. Inhibition of poliovirus replication by prostaglandins A and J in human cells. 1996 Antimicrob. Agents Chemother. pmid:8834882
Conti C et al. Antiviral effect of hyperthermic treatment in rhinovirus infection. 1999 Antimicrob. Agents Chemother. pmid:10103186
Caito S et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. 2008 Antioxid. Redox Signal. pmid:17970647
Gong P et al. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. 2002 Antioxid. Redox Signal. pmid:12006176
Jozkowicz A et al. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. 2002 Antioxid. Redox Signal. pmid:12230869
Jozkowicz A et al. 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress. 2008 Antioxid. Redox Signal. pmid:18665800
Amici C et al. Inhibition of Sendai virus replication by delta 12-prostaglandin J2: induction of heat shock protein synthesis and alteration of protein glycosylation. 1992 Antiviral Res. pmid:1332600
Parker J et al. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication. 1995 Antiviral Res. pmid:7537950
Pica F et al. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis. 1993 Antiviral Res. pmid:8385894
Han H et al. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. 2007 Apoptosis pmid:17786557
Rahman MS et al. Cultured preadipocytes undergoing stable transfection with cyclooxygenase-1 in the antisense direction accelerate adipogenesis during the maturation phase of adipocytes. 2013 Appl. Biochem. Biotechnol. pmid:23817787
Syeda PK et al. Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes. 2012 Appl. Biochem. Biotechnol. pmid:22391692
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acid. 1994 Arch Dermatol pmid:7979442
Leifke E et al. In vivo comparative study of the seizure- and ischemia-induced synthesis of eicosanoids in the brain of gerbils. 1994 Sep-Oct Arch Int Pharmacodyn Ther pmid:7710301
Hayaishi O et al. Genes for prostaglandin d synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep. 2004 Arch Ital Biol pmid:15493554
Watanabe T et al. NADP-linked 15-hydroxyprostaglandin dehydrogenase for prostaglandin D in human blood platelets. 1982 Arch. Biochem. Biophys. pmid:6954879
Sánchez-Gómez FJ et al. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. 2007 Arch. Biochem. Biophys. pmid:17169324
Koda N et al. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. 2004 Arch. Biochem. Biophys. pmid:15047184
Mueller C et al. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. 2003 Arch. Biochem. Biophys. pmid:14522590
Morii H and Watanabe Y A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. 1992 Arch. Biochem. Biophys. pmid:1309289
Morrow JD et al. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. 1998 Arch. Biochem. Biophys. pmid:9578611
Ujihara M et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. 1988 Arch. Biochem. Biophys. pmid:3041912
Oyama S et al. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells. 2014 Arch. Biochem. Biophys. pmid:24239863
Grunnet N et al. Absence of glycogen cycling in cultured rat hepatocytes. 1994 Arch. Biochem. Biophys. pmid:8117107
Herbertsson H et al. The 650-kDa 12(S)-hydroxyeicosatetraenoic acid binding complex: occurrence in human platelets, identification of hsp90 as a constituent, and binding properties of its 50-kDa subunit. 1999 Arch. Biochem. Biophys. pmid:10375396
Kitatani K et al. Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. 2001 Arch. Biochem. Biophys. pmid:11697858
Ujihara M et al. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. 1988 Arch. Biochem. Biophys. pmid:3124755
Ikai K and Fukushima M Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture. 1990 Arch. Dermatol. Res. pmid:1693839
Saarinen JV et al. Release of histamine and leukotriene C4 in immediate allergic wheal reaction as measured with the microdialysis technique. 2000 Arch. Dermatol. Res. pmid:10966057
Steinbrink K et al. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. 2000 Arch. Dermatol. Res. pmid:11000287
Zhang GY et al. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. 2009 Arch. Dermatol. Res. pmid:19466435
Furutani K et al. Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro. 1999 Jul-Aug Arch. Dermatol. Res. pmid:10482019
Ikai K et al. Ear swelling in response to UVB irradiation. 1986 Arch. Dermatol. Res. pmid:3466577
Kang HY et al. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. 2006 Arch. Dermatol. Res. pmid:16474974
Nittner-Marszalska M et al. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25763689
Kolaczkowska E et al. Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation. 2009 Nov-Dec Arch. Immunol. Ther. Exp. (Warsz.) pmid:19885646
Brown MS et al. Arachidonic acid metabolites during nasal challenge. 1987 Arch. Otolaryngol. Head Neck Surg. pmid:3099812
Kim SJ et al. Effects of methyl gallate on arachidonic acid metabolizing enzymes: Cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:17121182
Son MJ et al. Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:16681032
Hwang GS et al. Effects of Brazilin on the phospholipase A2 activity and changes of intracellular free calcium concentration in rat platelets. 1998 Arch. Pharm. Res. pmid:9868555
Choi YH et al. New anti-inflammatory formulation containing Synurus deltoides extract. 2005 Arch. Pharm. Res. pmid:16114500
Yang JH et al. Anti-allergic activity of an ethanol extract from Salviae miltiorrhiza. 2008 Arch. Pharm. Res. pmid:19099230
Jin M et al. Anti-inflammatory activity of 6-hydroxy-2,7-dimethoxy-1,4-henanthraquinone from tuberous roots of yam (Dioscorea batatas) through inhibition of prostaglandin Dâ‚‚ and leukotriene Câ‚„ production in mouse bone marrow-derived mast cells. 2011 Arch. Pharm. Res. pmid:21975811
Lee JJ et al. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. 2010 Arch. Pharm. Res. pmid:20361303
Zheng MS et al. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. 2008 Arch. Pharm. Res. pmid:18409044
Moon TC et al. The effects of isoimperatorin isolated from Angelicae dahuricae on cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2008 Arch. Pharm. Res. pmid:18365692
Lee CH and Edwards AM Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. 2003 Arch. Toxicol. pmid:12632255
Nakajima N et al. [Alternation of ion transport of airway epithelium by eicosanoids]. 2005 Arerugi pmid:16407682
Nagai H [The role of lipid mediators in allergic diseases]. 2007 Arerugi pmid:17615500
Itoh Y et al. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi]. 1993 Arerugi pmid:8279967
Buga GM et al. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:19965777
Kobayashi K et al. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23307871
Lin TN et al. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16385084
Hatoum OA et al. Novel mechanism of vasodilation in inflammatory bowel disease. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16141408
Polikandriotis JA et al. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16020752
Migita H and Morser J 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:15662020
Marx N et al. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. 1999 Arterioscler. Thromb. Vasc. Biol. pmid:10073956
Jackson SM et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. 1999 Arterioscler. Thromb. Vasc. Biol. pmid:10479650
Hofnagel O et al. Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15271788
Abe M et al. GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12615657
Levonen AL et al. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11701476
King VL et al. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16514081
Cipollone F et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15155382
Calnek DS et al. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12524224
Jung SM et al. Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels. 2007 Arthritis Res. Ther. pmid:17612394
Ulivi V et al. Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. 2011 Arthritis Res. Ther. pmid:21682897
Bianchi A et al. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. 2005 Arthritis Res. Ther. pmid:16277686
Farrajota K et al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. 2005 Arthritis Rheum. pmid:15641079